Leucine‐rich repeat kinase 2 (<scp>LRRK</scp>2) inhibitors differentially modulate glutamate release and Serine935 <scp>LRRK</scp>2 phosphorylation in striatal and cerebrocortical synaptosomes
Pharmacology research & perspectives